CLASS I Drug recall · Reported 28 May 2014 · FDA Enforcement Report

Xzone Gold blister 750 mg recalled by Schindele Enterprises

Schindele Enterprises is recalling Xzone Gold blister 750 mg, distributed in 13 states. The recall was initiated on 9 Jan 2014 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # 130710GL, Exp. 07/31/2018
Quantity recalled175 blister packs

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1334-2014
FDA event ID
67228
Recalling firm
Schindele Enterprises, Nixa, MO
Classification
Class I
Status
Terminated
Recall initiated
9 Jan 2014
FDA classified
20 May 2014
Reported
28 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Labeling Errors

Timeline

9 Jan 2014Recall initiated by company
20 May 2014Classified by FDA+131 days
28 May 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Product as listed by the FDA

XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL.

Where it was distributed

Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

CaliforniaConnecticutFloridaGeorgiaIowaIllinoisLouisianaMarylandNevadaNew YorkPennsylvaniaTexasWisconsin

Questions about this recall

Is Xzone Gold blister 750 mg recalled?

Yes. Schindele Enterprises recalled Xzone Gold blister 750 mg on 9 Jan 2014. The recall is Class I and its status is Terminated. Recall number D-1334-2014.

Why was it recalled?

Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Which lots are affected?

Lot # 130710GL, Exp. 07/31/2018

Where was it sold?

Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Schindele Enterprises

All 7